🇺🇸·Jul 8, 2023Industry
genentech and verana health track long term treatment of namd
Publisher
V
Verana Health
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Verana Health
- Region
- USA
- Scope
- Industry
- Published
- July 8, 2023
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on veranahealth.com
Leave the platform to read the original full article on the publisher site.
Source: Verana Health
Scope: Industry
Related coverage
More related coverage
Roche News RSS/3h ago
More details
Nippon Shinyaku News/7h ago
NS-025の全世界における開発・製造・販売に関する独占的ライセンス契約締結のお知らせ
Eli Lilly News/8h ago
Lilly confirms date and conference call for second-quarter 2026 financial results announcement
INDIANAPOLIS, July 22, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its seco...
GSK News/11h ago